プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
fold
3.2 darbiet
最終更新： 2017-04-26
使用頻度： 3
品質：
the primary endpoint in this study was the incidence of laboratory-confirmed clinical influenza as determined by viral culture and/or a four-fold rise in hai antibodies.
il-mira primarja ta’ dan l-istudju kienet l-inċidenza ta’ influwenza klinika kkonfermata fil-laboratorju kif determinat minn koltura virali u/jew żjieda għal erba’ darbiet fl-antikorpi hai.
data for group 3, subjects initially vaccinated with an h7n3 p/laiv are not shown. adays are counted relative to the only p/iiv dose for groups 1-4 and after the first of 2 p/iiv doses for group 5. bserological response defined as a ≥4-fold rise in antibody titer (≥ 1:20). cserum samples were available from 7 subjects in group 3 on day 28 and from 18 subjects in group 5 on day 56.
id-dejta għall-grupp 3, individwi li inizjalment tlaqqmu bil-p/laiv kontra h7n3 mhijiex murija. ail-ġranet huma magħduda fir-rigward tal-unika doża tal-p/iiv għall-gruppi 1-4 u wara l-ewwel doża miż-2 dożi tal-p/iiv għall-grupp 5. bir-rispons seroloġiku huwa definit bħala żieda ta’ ≥4-darbiet fit-titru tal-antikorpi (≥ 1:20). cil-kampjuni tas-serum kienu disponibbli minn 7 individwi fil-grupp 3 fil-jum 28 u minn 18-il individwu fil-grupp 5 fil-jum 56.